Marta Zalacaín

The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models

Naiara Martínez-Vélez, Marc García-Moure, Miguel Marigil et al. · Nature Communications · 2019 · 138 citations · Full text

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

Daniela Caronia, Ana Patiño‐García, Roger L. Milne et al. · The Pharmacogenomics Journal · 2009 · 133 citations

Osteosarcoma Patients, Medicine, Pathology +7

Methotrexate in Pediatric Osteosarcoma: Response and Toxicity in Relation to Genetic Polymorphisms and Dihydrofolate Reductase and Reduced Folate Carrier 1 Expression

Ana Patiño‐García, Marta Zalacaín, Lucía Marrodán et al. · The Journal of Pediatrics · 2009 · 87 citations

Genetic Polymorphisms, Oncogenic Agent, Medicine +7

Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study

Daniela Caronia, Ana Patiño‐García, Antonio Pérez‐Martínez et al. · PLoS ONE · 2011 · 86 citations · Full text

Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment

Patricio Molero, Felipe Ortuño, Marta Zalacaín et al. · The Pharmacogenomics Journal · 2007 · 79 citations

Psychiatry, Psychotic Disorder, Psychiatric Genetics +11